Source: Market Wire
Posted: September 8, 2006
Summary:
Healtheuniverse, Inc. (PINKSHEETS: HLUN), a diversified biotechnology development firm specializing in the development and commercialization of patented biopharmaceutical and biomedical products, announced that the Company's fat based stem cell technology is moving to clinical trials without the use of human embryonic stem cells.
Commentary: Hopefully these trials will provide insights into how to use fat based stem cells to treat medical conditions.
No comments:
Post a Comment